Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F van de Werf

Showing results (171-180 of 290) with videos related to

Pageof 29
Sort By:
Circulation|September 1, 1995
Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study GroupT Lenderink, M L Simoons, G A Van Es, et al.
Circulation|October 1, 1990
Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction. European Cooperative Study Group for Recombinant Tissue-Type Plasminogen ActivatorJ L Willems, R J Willems, G M Willems, et al.
European Heart Journal|June 29, 2001
The general concepts of an equivalence trial, applied to ASSENT-2, a large-scale mortality study comparing two fibrinolytic agents in acute myocardial infarctionE Lesaffre, E Bluhmki, F Wang-Clow, et al.
European Heart Journal|May 1, 1994
Early and late exercise capacity after acute myocardial infarction treated with recombinant tissue-plasminogen activatorT Brzostek, F Van de Werf, L Mortelmans, et al.
Academic Radiology|April 30, 1998
Validation of intracoronary delivery of metalloporphyrin as an in vivo "histochemical staining" for myocardial infarction with MR imagingY Ni, C Pislaru, H Bosmans, et al.
Angiology|January 1, 1995
Determinants of left ventricular function two weeks and one year after an acute myocardial infarctionT Brzostek, F Van de Werf, I Scheys, et al.
Cardiovascular Research|January 1, 1997
Thrombolysis-induced coronary reperfusion causes acute and massive interstitial release of cardiac muscle cell proteinsC Cobbaert, W T Hermens, P P Kint, et al.
Heart (British Cardiac Society)|October 13, 2007
Risk stratification in ST-elevation myocardial infarction is enhanced by combining baseline ST deviation and subsequent ST-segment resolutionM Toma, Y Fu, G Wagner, et al.
Acta Cardiologica|January 1, 1994
Cardiac transplantation in giant cell myocarditis. A case reportC Laruelle, J Vanhaecke, F Van de Werf, et al.
Acta Cardiologica|January 1, 1986
Closed chest myocardial biopsies: clinical uses and related problemsL G Shu, H de Geest, H Kesteloot, et al.
Pageof 29

Showing results (171-180 of 290) with videos related to

Sort By:
Pageof 29
Circulation|September 1, 1995
Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study GroupT Lenderink, M L Simoons, G A Van Es, et al.
Circulation|October 1, 1990
Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction. European Cooperative Study Group for Recombinant Tissue-Type Plasminogen ActivatorJ L Willems, R J Willems, G M Willems, et al.
European Heart Journal|June 29, 2001
The general concepts of an equivalence trial, applied to ASSENT-2, a large-scale mortality study comparing two fibrinolytic agents in acute myocardial infarctionE Lesaffre, E Bluhmki, F Wang-Clow, et al.
European Heart Journal|May 1, 1994
Early and late exercise capacity after acute myocardial infarction treated with recombinant tissue-plasminogen activatorT Brzostek, F Van de Werf, L Mortelmans, et al.
Academic Radiology|April 30, 1998
Validation of intracoronary delivery of metalloporphyrin as an in vivo "histochemical staining" for myocardial infarction with MR imagingY Ni, C Pislaru, H Bosmans, et al.
Angiology|January 1, 1995
Determinants of left ventricular function two weeks and one year after an acute myocardial infarctionT Brzostek, F Van de Werf, I Scheys, et al.
Cardiovascular Research|January 1, 1997
Thrombolysis-induced coronary reperfusion causes acute and massive interstitial release of cardiac muscle cell proteinsC Cobbaert, W T Hermens, P P Kint, et al.
Heart (British Cardiac Society)|October 13, 2007
Risk stratification in ST-elevation myocardial infarction is enhanced by combining baseline ST deviation and subsequent ST-segment resolutionM Toma, Y Fu, G Wagner, et al.
Acta Cardiologica|January 1, 1994
Cardiac transplantation in giant cell myocarditis. A case reportC Laruelle, J Vanhaecke, F Van de Werf, et al.
Acta Cardiologica|January 1, 1986
Closed chest myocardial biopsies: clinical uses and related problemsL G Shu, H de Geest, H Kesteloot, et al.
Pageof 29